438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- - College of Physicians - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-05-29 06:55:23 Pharmacology Monoclonal antibodies Centocor Health Ustekinumab Psoriatic nails Etanercept Psoriatic arthritis Biologic Immunosuppressants Psoriasis Medicine		438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- Add to Reading List Source URL: preview.thenewsmarket.com Download Document from Source Website File Size: 212,21 KB Share Document on Facebook

	Ixekizumab for moderate to severe chronic plaque psoriasis DocID: 1gyoS - View Document
	438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- DocID: 1fNC6 - View Document
	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement DocID: 1a6Du - View Document
	Infliximab (Remicade®) and Pregnancy In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to inflixi DocID: 1a5mb - View Document
	Microsoft Word - 106937148_19 DocID: 19ODp - View Document